Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Pathogens (Basel, Switzerland)|July 27, 2022
Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality ParametersKatarina Kovacic Krizanic, Florian Prüller, Konrad Rosskopf, et al.
Transfusion|October 27, 2015
Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasisSusanne Macher, Thomas Wagner, Konrad Rosskopf, et al.
Journal of Medical Virology|November 19, 2011
Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivationBastian A Vogl, Ursula Fagin, Linda Nerbas, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 30, 2004
Search for atypical lymphocytes in schizophreniaSebastian Rudolf, Peter Schlenke, Andreas Broocks, et al.
Biochemical Pharmacology|April 19, 2002
Stem cell toxicity of oxazaphosphorine metabolites in comparison to their antileukemic activitySvenja K Brueggemann, Peter Schlenke, Stephanie Klich, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 20, 2017
Emergence of CD43-Expressing Hematopoietic Progenitors from Human Induced Pluripotent Stem CellsKatharina U Kessel, Anika Bluemke, Hans R Schöler, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 15, 2003
Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytesChristoph Härtel, Hans-Jörg Hammers, Peter Schlenke, et al.
Journal of Clinical Microbiology|December 10, 2003
Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriersSusanne Maurmann, Lutz Fricke, Hans-Joachim Wagner, et al.
Annals of Hematology|April 20, 2011
Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patientsPeter Schlenke, Wibke Hagenah, Johannes Irsch, et al.
BMC Cell Biology|December 22, 2009
Murine mesenchymal progenitor cells from different tissues differentiated via mesenchymal microspheres into the mesodermal directionFlorian Böhrnsen, Ulrich Lindner, Markus Meier, et al.
Pageof 9